Veritas drives genomic innovation and showcases pioneering research at European Human Genetics Conference 2025 in Milan May 29, 2025
Veritas highlights value in cancer and prevention at UK cancer genetics group spring meeting May 13, 2025
Veritas Genetics reaches an agreement with Apposite Capital and other shareholders, for the full acquisition of NIMGenetics, leading the future of medical genetics January 16, 2025
Veritas Genetics participates in a groundbreaking study highlighting the importance of polygenic risk scores in the clinical management of breast cancer patients October 4, 2024
Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference – ESHG 2024 May 30, 2024
